Company / CapEx per Share
AbCellera Biologics Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.14
FY2025
5-year range
$0.01 / $0.27
FY2021-FY2025
Trend
-46.4%
vs FY2024
Sector context
#50 of 192
Health Care
What the data says
At $0.14, AbCellera Biologics Inc.'s capex per share ranks #50 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2021 to $0.27 in FY2024.
Based on SEC 10-K filings.
0.14 in FY2025 with a 5-year CAGR of +31.5%.
Declined from $0.27 to $0.14 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +61.8%
- 5-Year CAGR
- +31.5%
- 10-Year CAGR
- -
Sector benchmark
#50 of 192 in Health CareTop 26% of 192This company $0.14 Sector average $2.46
▼
-94.1% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 46.4% year-over-year.
- Ranks #50 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | -46.4% |
| FY2024 | $0.27 | +0.5% |
| FY2023 | $0.27 | +685.5% |
| FY2022 | $0.03 | +130.3% |
| FY2021 | $0.01 | -59.7% |
| FY2020 | $0.04 | +39.2% |
| FY2019 | $0.03 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026